ID   NPFF2_HUMAN             Reviewed;         522 AA.
AC   Q9Y5X5; Q96RV1; Q9NR49;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   07-APR-2021, entry version 174.
DE   RecName: Full=Neuropeptide FF receptor 2;
DE   AltName: Full=G-protein coupled receptor 74;
DE   AltName: Full=G-protein coupled receptor HLWAR77;
DE   AltName: Full=Neuropeptide G-protein coupled receptor;
GN   Name=NPFFR2; Synonyms=GPR74, NPFF2, NPGPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetus;
RX   PubMed=10079187; DOI=10.1006/bbrc.1999.0332;
RA   Cikos S., Gregor P., Koppel J.;
RT   "Sequence and tissue distribution of a novel G-protein-coupled receptor
RT   expressed prominently in human placenta.";
RL   Biochem. Biophys. Res. Commun. 256:352-356(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=10851242; DOI=10.1074/jbc.m004515200;
RA   Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K.,
RA   Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M.,
RA   Murdock P.R., Milligan G., Groarke D.A., Tan K.B., Shabon U.,
RA   Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., Sarau H.M.;
RT   "Receptor for the pain modulatory neuropeptides FF and AF is an orphan G
RT   protein-coupled receptor.";
RL   J. Biol. Chem. 275:25965-25971(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHARACTERIZATION.
RC   TISSUE=Spinal cord;
RX   PubMed=11024015; DOI=10.1074/jbc.m004385200;
RA   Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M.,
RA   Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.-J.,
RA   Ogozalek K.L., Boyle N., Kouranova E.V., Quan Y., Vaysse P.J., Wetzel J.M.,
RA   Branchek T.A., Gerald C., Borowsky B.;
RT   "Identification and characterization of two G protein-coupled receptors for
RT   neuropeptide FF.";
RL   J. Biol. Chem. 275:39324-39331(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=10837915; DOI=10.1016/s0169-328x(00)00052-8;
RA   Parker R.M.C., Copeland N.G., Eyre H.J., Liu M., Gilbert D.J., Crawford J.,
RA   Couzens M., Sutherland G.R., Jenkins N.A., Herzog H.;
RT   "Molecular cloning and characterisation of GPR74 a novel G-protein coupled
RT   receptor closest related to the Y-receptor family.";
RL   Brain Res. Mol. Brain Res. 77:199-208(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Liu Q., Guan X.-M., McDonald T.P., Jiang Q., Zeng Z., Marlene J.,
RA   Williams D.L. Jr., Hong Y., Figueroa D., Clements M.K., Mallee J., Wang R.,
RA   Evans J., Gould R., Austin C.P.;
RT   "Identification and characterization of two cognate receptors for mammalian
RT   FMRFamide-like neuropeptides.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RA   Laemmle B.S., Schindler M., Beilmann M., Hamilton B.S., Doods H.N.,
RA   Wieland H.A.;
RT   "Cloning and characterization of the NPGP receptor and identification of a
RT   novel short mRNA isoform in human hypothalamus.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for NPAF (A-18-F-amide) and NPFF (F-8-F-amide)
CC       neuropeptides, also known as morphine-modulating peptides. Can also be
CC       activated by a variety of naturally occurring or synthetic FMRF-amide
CC       like ligands. This receptor mediates its action by association with G
CC       proteins that activate a phosphatidylinositol-calcium second messenger
CC       system.
CC   -!- INTERACTION:
CC       Q9Y5X5-3; Q9Y680: FKBP7; NbExp=3; IntAct=EBI-18076879, EBI-3918971;
CC       Q9Y5X5-3; A2RU14: TMEM218; NbExp=3; IntAct=EBI-18076879, EBI-10173151;
CC       Q9Y5X5-3; A5PKU2: TUSC5; NbExp=3; IntAct=EBI-18076879, EBI-11988865;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=1; Synonyms=long form;
CC         IsoId=Q9Y5X5-1; Sequence=Displayed;
CC       Name=2; Synonyms=short form;
CC         IsoId=Q9Y5X5-2; Sequence=VSP_001907;
CC       Name=3;
CC         IsoId=Q9Y5X5-3; Sequence=VSP_001908, VSP_001909;
CC       Name=4;
CC         IsoId=Q9Y5X5-4; Sequence=VSP_001910, VSP_001911;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is abundant in placenta. Relatively
CC       highly expressed in thymus, testis, and small intestine. Expressed at
CC       low levels in several tissues including spleen, prostate, brain, heart,
CC       ovary, colon, kidney, lung, liver and pancreas and not expressed in
CC       skeletal muscle and leukocytes. Isoform 2 expression is highest in
CC       placenta (but at relatively low level compared to isoform 1). Very low
CC       level of expression in numerous tissues including adipose tissue and
CC       many brain regions. Isoform 3 is expressed in brain and heart and, at
CC       lower levels, in kidney, liver, lung and pancreas.
CC       {ECO:0000269|PubMed:10079187}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK58513.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF119815; AAD22047.1; -; mRNA.
DR   EMBL; AF257210; AAF87078.1; -; mRNA.
DR   EMBL; AF268899; AAG41398.1; -; mRNA.
DR   EMBL; AF236083; AAK58513.1; ALT_FRAME; mRNA.
DR   EMBL; AF330053; AAK94197.1; -; mRNA.
DR   EMBL; AJ311393; CAC85427.1; -; mRNA.
DR   CCDS; CCDS3551.1; -. [Q9Y5X5-2]
DR   CCDS; CCDS3552.1; -. [Q9Y5X5-2]
DR   CCDS; CCDS47072.1; -. [Q9Y5X5-3]
DR   RefSeq; NP_001138228.1; NM_001144756.1. [Q9Y5X5-3]
DR   RefSeq; NP_004876.2; NM_004885.2. [Q9Y5X5-2]
DR   RefSeq; NP_444264.1; NM_053036.2. [Q9Y5X5-2]
DR   SMR; Q9Y5X5; -.
DR   BioGRID; 116093; 3.
DR   IntAct; Q9Y5X5; 3.
DR   STRING; 9606.ENSP00000307822; -.
DR   BindingDB; Q9Y5X5; -.
DR   ChEMBL; CHEMBL5952; -.
DR   GuidetoPHARMACOLOGY; 301; -.
DR   GlyGen; Q9Y5X5; 4 sites.
DR   iPTMnet; Q9Y5X5; -.
DR   PhosphoSitePlus; Q9Y5X5; -.
DR   BioMuta; NPFFR2; -.
DR   DMDM; 13878604; -.
DR   EPD; Q9Y5X5; -.
DR   PaxDb; Q9Y5X5; -.
DR   PeptideAtlas; Q9Y5X5; -.
DR   PRIDE; Q9Y5X5; -.
DR   ProteomicsDB; 86531; -. [Q9Y5X5-1]
DR   ProteomicsDB; 86532; -. [Q9Y5X5-2]
DR   ProteomicsDB; 86533; -. [Q9Y5X5-3]
DR   ProteomicsDB; 86534; -. [Q9Y5X5-4]
DR   Antibodypedia; 3469; 214 antibodies.
DR   Ensembl; ENST00000308744; ENSP00000307822; ENSG00000056291. [Q9Y5X5-1]
DR   Ensembl; ENST00000344413; ENSP00000340789; ENSG00000056291. [Q9Y5X5-4]
DR   Ensembl; ENST00000358749; ENSP00000351599; ENSG00000056291. [Q9Y5X5-2]
DR   Ensembl; ENST00000395999; ENSP00000379321; ENSG00000056291. [Q9Y5X5-3]
DR   GeneID; 10886; -.
DR   KEGG; hsa:10886; -.
DR   UCSC; uc003hgg.3; human. [Q9Y5X5-1]
DR   CTD; 10886; -.
DR   DisGeNET; 10886; -.
DR   GeneCards; NPFFR2; -.
DR   HGNC; HGNC:4525; NPFFR2.
DR   HPA; ENSG00000056291; Tissue enhanced (lymphoid tissue, seminal vesicle).
DR   MIM; 607449; gene.
DR   neXtProt; NX_Q9Y5X5; -.
DR   OpenTargets; ENSG00000056291; -.
DR   PharmGKB; PA28918; -.
DR   VEuPathDB; HostDB:ENSG00000056291.17; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01020000230390; -.
DR   HOGENOM; CLU_1916367_0_0_1; -.
DR   InParanoid; Q9Y5X5; -.
DR   OMA; YVDYYLH; -.
DR   OrthoDB; 1308959at2759; -.
DR   PhylomeDB; Q9Y5X5; -.
DR   TreeFam; TF315303; -.
DR   PathwayCommons; Q9Y5X5; -.
DR   Reactome; R-HSA-389397; Orexin and neuropeptides FF and QRFP bind to their respective receptors.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   SIGNOR; Q9Y5X5; -.
DR   BioGRID-ORCS; 10886; 3 hits in 982 CRISPR screens.
DR   ChiTaRS; NPFFR2; human.
DR   GenomeRNAi; 10886; -.
DR   Pharos; Q9Y5X5; Tchem.
DR   PRO; PR:Q9Y5X5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9Y5X5; protein.
DR   Bgee; ENSG00000056291; Expressed in chorionic villus and 80 other tissues.
DR   ExpressionAtlas; Q9Y5X5; baseline and differential.
DR   Genevisible; Q9Y5X5; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0008188; F:neuropeptide receptor activity; IEA:InterPro.
DR   GO; GO:0031628; F:opioid receptor binding; IEA:InterPro.
DR   GO; GO:0042277; F:peptide binding; IBA:GO_Central.
DR   GO; GO:0009582; P:detection of abiotic stimulus; TAS:ProtInc.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0045761; P:regulation of adenylate cyclase activity; IEA:InterPro.
DR   GO; GO:2000479; P:regulation of cAMP-dependent protein kinase activity; IEA:InterPro.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IEA:InterPro.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR005395; NPFF_rcpt.
DR   InterPro; IPR005397; NPFF_rcpt_2.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01570; NPFFRECEPTOR.
DR   PRINTS; PR01572; NPFFRECEPTR2.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..522
FT                   /note="Neuropeptide FF receptor 2"
FT                   /id="PRO_0000069915"
FT   TOPO_DOM        1..147
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        148..168
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        169..184
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        185..205
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        206..221
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        222..242
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        243..262
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        263..283
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        284..319
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        320..340
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        341..377
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        378..398
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        399..413
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        414..434
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        435..522
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        110
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        122
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        220..308
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VAR_SEQ         1..102
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10851242,
FT                   ECO:0000303|PubMed:11024015, ECO:0000303|Ref.5"
FT                   /id="VSP_001907"
FT   VAR_SEQ         1..99
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10837915"
FT                   /id="VSP_001908"
FT   VAR_SEQ         100
FT                   /note="R -> M (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10837915"
FT                   /id="VSP_001909"
FT   VAR_SEQ         101..132
FT                   /note="FIMNEKWDTNSSENWHPIWNVNDTKHHLYSDI -> MAIWKHDVQDQWIGPG
FT                   NICRSFSLYVSCNCCR (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_001910"
FT   VAR_SEQ         133..522
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_001911"
FT   CONFLICT        466
FT                   /note="A -> T (in Ref. 1 and 4)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   522 AA;  60270 MW;  40CB9FCD42F77041 CRC64;
     MNSFFGTPAA SWCLLESDVS SAPDKEAGRE RRALSVQQRG GPAWSGSLEW SRQSAGDRRR
     LGLSRQTAKS SWSRSRDRTC CCRRAWWILV PAADRARRER FIMNEKWDTN SSENWHPIWN
     VNDTKHHLYS DINITYVNYY LHQPQVAAIF IISYFLIFFL CMMGNTVVCF IVMRNKHMHT
     VTNLFILNLA ISDLLVGIFC MPITLLDNII AGWPFGNTMC KISGLVQGIS VAASVFTLVA
     IAVDRFQCVV YPFKPKLTIK TAFVIIMIIW VLAITIMSPS AVMLHVQEEK YYRVRLNSQN
     KTSPVYWCRE DWPNQEMRKI YTTVLFANIY LAPLSLIVIM YGRIGISLFR AAVPHTGRKN
     QEQWHVVSRK KQKIIKMLLI VALLFILSWL PLWTLMMLSD YADLSPNELQ IINIYIYPFA
     HWLAFGNSSV NPIIYGFFNE NFRRGFQEAF QLQLCQKRAK PMEAYALKAK SHVLINTSNQ
     LVQESTFQNP HGETLLYRKS AEKPQQELVM EELKETTNSS EI
//
